Skip to main content
Fig. 3 | Molecular Autism

Fig. 3

From: Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial

Fig. 3

Change in treatment responses according to the presence of concomitant psychosocial training. Visualization of changes from baseline in parent-reported social responsiveness (SRS-2 raw total scores) of the double-blind phase (phase I), separately for children receiving only the oxytocin (n = 28) or placebo (n = 30) nasal spray and children receiving oxytocin (n = 10) or placebo (n = 8) nasal spray in combination with concomitant psychosocial trainings (pooled across the immediate post and four-week follow-up sessions of phase I). Lower scores indicate improvement. Vertical bars denote ± standard errors

Back to article page

Molecular Autism

ISSN: 2040-2392